HENDERSON, Nev., April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the successful detection of nucleosomes in capillary blood from critically ill sepsis patients...
Hence then, the article about volition announces breakthrough finger prick detection of nucleosomes expanding global market potential for sepsis testing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing )
Also on site :
- Burnham pledges more cost of living support as chancellor says public being ‘taken for a ride’ on food and petrol prices
- What channel is Hibs v Motherwell Scottish Premiership match on? TV coverage, live stream and kick-off time
- An Award-Winning Restaurant Chef Is Begging People to Stop Doing This One Thing With Chicken—and Do This Instead